Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1
Conditions: Myotonic Dystrophy 1; Excessive Daytime Sleepiness Interventions: Drug: Pitolisant Oral Tablet; Drug: Placebo oral tablet Sponsor: Harmony Biosciences, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Reflex Sympathetic Dystrophy | Research